xolairhcp.com
Summary
XOLAIR® (omalizumab) is a medication indicated for the treatment of moderate to severe persistent asthma, chronic rhinosinusitis with nasal polyps, and IgE-mediated food allergies.
Associated Brands
IAB Categories
Health & Fitness
IAB Ad Products
Health and Medical ServicesPharmaceuticals
Tags
Creatives
| ID | Domain | Seat | Bid | Timestamp | Status | Ad Format | Sub Format | Size | Quality Score | Data Transferred | Computational Cost |
|---|---|---|---|---|---|---|---|---|---|---|---|
| cmigck | Xandr | $1.31 | 11/26/2025, 6:37:25 PM | Ad Analysis: Success Domain Analysis: Success Domain Capture: Success Ad Rendering: Success Brand Mapping: Success | banner | - | 300x250 | 7/10 | 722.66 KB | 7355.00 ms | |
| cmi7ne | Xandr | $5.42 | 11/20/2025, 4:30:59 PM | Ad Analysis: Success Domain Analysis: Success Ad Rendering: Success Brand Mapping: Success Domain Capture: Failed | banner | - | 320x50 | 7/10 | 722.90 KB | 7418.00 ms | |
| cmi546 | PP | $1.37 | 11/18/2025, 9:57:02 PM | Ad Analysis: Success Domain Analysis: Success Domain Capture: Success Ad Rendering: Success Brand Mapping: Success | banner | - | 320x50 | 6/10 | 669.63 KB | 8468.00 ms | |
| cmi3ge | PP | $0.08 | 11/17/2025, 6:03:43 PM | Ad Analysis: Success Domain Analysis: Success Domain Capture: Success Ad Rendering: Success Brand Mapping: Success | banner | - | 320x50 | 6/10 | 670.91 KB | 8567.00 ms | |
| cmhthm | PP | $0.15 | 11/10/2025, 6:40:25 PM | Ad Analysis: Success Domain Analysis: Success Domain Capture: Success Ad Rendering: Success Brand Mapping: Success | banner | - | 300x250 | 6/10 | 940.12 KB | 9126.00 ms | |
| cmhe83 | PP | $31.35 | 10/31/2025, 2:17:27 AM | Ad Analysis: Success Domain Analysis: Success Domain Capture: Success Ad Rendering: Success Brand Mapping: Success | banner | - | 300x50 | 6/10 | 678.66 KB | 8109.00 ms |